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RESULTS: During the four week period prior to the
survey, allergic respondents reported missing a total 
of 16.4 hours of work; 1.97, 2.54, and 11.91 hours 
were due to full days missed, partial missed days, and 
presenteeism, respectively. On average, for presenteeism,
respondents reported working 6 of 20 days when their
allergy symptoms were worse than normal, and rated
themselves as 75% productive on these days. A stepwise
linear regression identiﬁed a) symptomatology, b) allergy-
related physician visits, c) severity of medication side
effects, d) younger age, e) overall rating of allergy 
severity, f) lower education, g) receipt of allergy shots,
and h) low knowledge of allergies as statistically signiﬁ-
cant predictors (p < .05) of reduced productivity.
CONCLUSIONS: Data from this study conﬁrm earlier
research ﬁndings of the substantial disease burden 
associated with allergic rhinitis. Extrapolating to a full
year, employees with allergic rhinitis could be expected to 
lose 213 hours of productivity, which at $20/hour wage
rate translates into $4,260. Patient knowledge (self-
management behaviors) and use of medications with
fewer side effects (non-sedating antihistamines) are 
associated with increased productivity suggesting that
various disease management strategies could be highly
cost-effective.
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The most widely cited studies on the costs of allergic
rhinitis predate the use of non-sedating antihistamines
and inhaled corticosteroids.
OBJECTIVE: Our objectives were to update U.S. esti-
mates of the direct and indirect costs of allergic rhinitis
and to estimate prescription medication expenditures by
prescription drug coverage.
METHODS: Data from the 1996 Medical Expenditure
Panel Survey (MEPS) were used in a cross-sectional 
analysis of resource utilization and costs for allergic 
rhinitis.
RESULTS: Approximately 6.5% (21 million) of the U.S.
noninstitutionalized civilian population was estimated to
experience allergic rhinitis during 1996, of which approx-
imately 62% sought medical treatment (i.e., a visit to a
medical provider or receipt of a prescribed medicine). The
total cost of allergic rhinitis was estimated at $3.1 billion.
Prescription medications comprised 43% ($1.5 billion) 
of the total cost and ofﬁce/clinic visits comprised 40% 
($1.4 billion). Twenty-three percent of the prescription 
medication expenditures were spent on second-generation
antihistamines, 24% on inhaled corticosteroids, and 13%
on sedating antihistamines. Allergic rhinitis was associ-
ated with approximately 3.3 million missed workdays
and 1.5 million missed school days. Fifty-six percent 
of patients with allergic rhinitis received at least one 
prescription drug over the study year. Among these 
individuals, average prescription expenditures were $113
(95% CI, [$113, $124]), of which, $28 (95% CI, [$24,
$33]) was paid out-of-pocket. The mean prescription
medication expenditure was $153 (95% CI, [$135,
$171]) for subjects with private insurance, $43 (95% CI,
[$33, $53]) for individuals with no supplemental insur-
ance, $103 (95% CI, [$69, $137]) for subjects with
Medicare and/or Medicaid, and $211 (95% CI, [$95,
$327]) with any other third party coverage.
CONCLUSION: Prescription medications represent a
substantial proportion of the total cost of allergic 
rhinitis. Average expenditures for prescription medica-
tions vary by prescription drug coverage.
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Over-estimation is an important drawback of the 
Human-capital approach (HCA) of calculating cost of
lost productivity. Also, there is insufﬁcient empirical
research regarding the use of Friction-cost approach
(FCA) in calculating cost of lost productivity. These
factors have acted as barrier to incorporation of cost of
lost productivity in cost analyses studies.
OBJECTIVES: This study seeks to estimate and compare
cost of lost productivity by Human-Capital Approach
(HCA) and Friction-Cost Approach (FCA) in patients
with asthma.
METHODS: Cross-sectional analysis was conducted
using MEPS household component and medical condition
survey, 1996. Patients with asthma (ICD-9: 493), who
were between the ages 16 to 65 years and had missed, at
minimum, half a day of work were selected. Missed hours
due to illness, hourly wages and beneﬁts were calculated
based on data provided in MEPS and Bureau of Labor
statistics. Costs of lost productivity were estimated using
the HCA and FCA methods.
RESULTS: Of the 65 patients who were included in the
study, 59% were full-time workers, 32% were part-time
workers and 9% had changed their work status during
the study period. Estimated total cost of lost productivity
for 56 patients, by HCA, in 1996 was US$ 113,877 (1996
dollars). While, according to FCA, the estimated total
cost of lost productivity ranged between US$ 64,014 and
US$ 81,723 (1996 dollars).
CONCLUSION: The study results demonstrate that FCA
estimates of cost of lost productivity are relatively lower
as compared to HCA estimate. Also, depending on
assumptions considered in FCA, there could be large 
variations in cost of lost productivity, as observed in this
study. Therefore, for meaningful incorporation of lost
productivity in cost-analysis studies further reﬁnement of
these two methods is implied.
